The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Logic-gated, allogeneic Tmod chimeric antigen receptor T-cell (CAR T) therapy targeting epidermal growth factor receptor (EGFR) in advanced solid tumors with human leukocyte antigen (HLA) loss of heterozygosity (LOH): DENALI-1 trial.
 
Kedar Kirtane
Leadership - MyCareGorithm
Stock and Other Ownership Interests - Agenus; Oncternal Therapeutics; Veru
Consulting or Advisory Role - MyCareGorithm
Research Funding - Turnstone Bio
Travel, Accommodations, Expenses - A2Bio
 
Jong Chul Park
Honoraria - Coherus Biosciences; MitoImmune; Selecxine
Consulting or Advisory Role - Hanall Biopharma; Hanmi Pharma
Research Funding - A2 Bio (Inst); A2 Biotherapeutics (Inst); Alentis Therapeutics (Inst); ALX Oncology (Inst); Ankyra Therapeutics (Inst); CUE Biopharma (Inst); InhibRx (Inst); ISA Pharmaceuticals (Inst)
 
Matthew Ulrickson
Consulting or Advisory Role - ADC Therapeutics; Autolus; Bristol-Myers Squibb/Celgene/Juno; Genentech; Kura Oncology; Stemline Therapeutics
Research Funding - Immunogen; Kite, a Gilead company
Travel, Accommodations, Expenses - Miltenyi Biotec
 
Deborah Wong
Consulting or Advisory Role - Coherus Biosciences; Merck; RAPT Therapeutics
Research Funding - AstraZeneca/MedImmune (Inst); Bicara Therapeutics (Inst); BioNTech SE (Inst); Bristol-Myers Squibb (Inst); Elevar Therapeutics (Inst); Enzychem Lifesciences (Inst); Flamingo Pharma (Inst); FSTAR (Inst); Genentech/Roche (Inst); Gilead Sciences (Inst); GlaxoSmithKline (Inst); Hookipa Biotech (Inst); invoX pharma (Inst); Lilly; Lilly (Inst); Merck Sharp & Dohme (Inst); Pfizer (Inst); Regeneron (Inst); Sensei Biotherapeutics (Inst); TopAlliance BioSciences Inc (Inst)
 
John Sunwoo
Employment - Stanford Health Care
Stock and Other Ownership Interests - Amgen; Biocurex; Indapta Therapeutics
Consulting or Advisory Role - Indapta Therapeutics
Research Funding - NIH
Patents, Royalties, Other Intellectual Property - Stanford has issued a patent on tissue-resident NK cell work performed in my role at Stanford.
 
Julian Molina
No Relationships to Disclose
 
David Maloney
Stock and Other Ownership Interests - A2 Biotherapeutics
Honoraria - A2 Biotherapeutics; Bristol-Myers Squibb/Celgene; Genentech/Roche; Gilead Sciences; Kite, a Gilead company; Lyell Immunopharma; Novartis; Umoja Biopharma
Consulting or Advisory Role - A2 Biotherapeutics; Celgene/Bristol-Myers Squibb; Genentech; NAVAN Technologies
Research Funding - Celgene (Inst); Juno Therapeutics (Inst); Kite, a Gilead company (Inst)
Patents, Royalties, Other Intellectual Property - Inventor on 4 provisional patents.
 
Marcela Maus
Leadership - 2seventy bio
Stock and Other Ownership Interests - 2seventy bio; A2Bio; Affyimumune; BendBio; CARGO Therapeutics; GBM newco; Model T Bio; NexImmune; Oncternal Therapeutics
Consulting or Advisory Role - Adaptimmune; AffyImmune Therapeutics; Agenus; arcellx; Astellas Pharma; AstraZeneca; Atara Biotherapeutics; Bayer; BMS; Cabaletta Bio; Cabaletta Bio; Chugai Pharma; crispr therapeutics; GlaxoSmithKline; In8Bio; In8bio; Intellia Therapeutics; Kite, a Gilead company; MicroMedicine; Novartis; Oncternal Therapeutics; Sanofi; TCR2 Therapeutics; Tmunity Therapeutics, Inc.; Torque; windmil
Research Funding - Kite, a Gilead company (Inst); Moderna Therapeutics (Inst); Servier (Inst); Sobi (Inst)
Patents, Royalties, Other Intellectual Property - Inventor on patents held by Massachusetts General Hospital/Partners Health care; all related to CAR T cells and/or gene therapy; Inventor on patents held by U. Pennsylvania with and without Novartis
 
Harry Fuentes Bayne
No Relationships to Disclose
 
Patrick Grierson
Employment - Walgreens (I)
Honoraria - AstraZeneca
Consulting or Advisory Role - AstraZeneca
Patents, Royalties, Other Intellectual Property - Compositions and Methods for the Treatment of Pancreatic Cancer
 
Salman Punekar
Research Funding - A2 Biotherapeutics (Inst); Affini-T Therapeutics (Inst); Amgen (Inst); Astellas Pharma (Inst); Constellation Pharmaceuticals (Inst); NCI (Inst); Neogene Therapeutics (Inst); Prelude Therapeutics (Inst); Revolution Medicines (Inst); Simcere (Inst); Tango Therapeutics (Inst); VITRAC Therapeutics (Inst)
 
Frederick Locke
Consulting or Advisory Role - A2 Biotherapeutics; Alimera Sciences; Amgen; Bluebird Bio; Bristol-Myers Squibb; Bristol-Myers Squibb/Celgene; Calibr; Caribou Biosciences; Celgene; Cowen; Daiichi Sankyo/UCB Japan; EcoR1 Capital; Gerson Lehrman Group; Iovance Biotherapeutics; Janssen; Kite, a Gilead company; Legend Biotech; Miltenyi Biotec; Novartis; Sana Biotechnology; Takeda; Takeda; Umoja Biopharma
Research Funding - Alimera Sciences (Inst); Bluebird Bio (Inst); Bristol-Myers Squibb/Celgene (Inst); Kite, a Gilead company (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - CAR T Cells with Enhanced Metabolic Fitness. Serial Number: 62/939,727 (Inst); Double Mutant Survivin Vaccine. US010414810B2. (Inst); Evolutionary Dynamics of Non-Hodgkin Lymphoma CAR-T cell therapy. Serial Number: 62/879,534. (Inst); Methods of Enhancing CAR T Cell Therapies. Serial Number: 62/892,292. (Inst)
Travel, Accommodations, Expenses - A2 Biotherapeutics; Kite, a Gilead company
 
Marco Davila
No Relationships to Disclose
 
Rebecca Shatsky
Consulting or Advisory Role - AstraZeneca; Daiichi Sankyo/Astra Zeneca; Endeavor BioMedicines; Guardant Health; Lilly; Novartis; Stemline Therapeutics; TEMPUS
Research Funding - AstraZeneca (Inst); Briacell (Inst); Gilead Sciences (Inst); Greenwich LifeSciences (Inst); OBI Pharma (Inst); OnKure (Inst); QuantumLeap Health (Inst); Regor Therapeutics (Inst); Stemline Therapeutics (Inst)
 
Wendy Langeberg
Employment - A2 Biotherapeutics
Stock and Other Ownership Interests - A2 Biotherapeutics
 
William Go
Employment - A2 Biotherapeutics
Stock and Other Ownership Interests - A2 Biotherapeutics
 
Eric Ng
Employment - A2 Biotherapeutics; Amgen
Stock and Other Ownership Interests - A2 Biotherapeutics; Amgen
Travel, Accommodations, Expenses - A2 Biotherapeutics; Amgen
 
John Welch
Employment - A2 Biotherapeutics
Stock and Other Ownership Interests - A2 Biotherapeutics
Consulting or Advisory Role - Agios; Archer
Research Funding - Janssen (Inst); Notable Labs (Inst)
 
Joel Hecht
Stock and Other Ownership Interests - Actym Therapeutics; Rafael Pharmaceuticals; Trumvira
Consulting or Advisory Role - Agenus; Astellas Pharma; BeiGene; Bristol-Myers Squibb/Medarex; Galvanize Therapeutics; MBQ Pharma; Revolution Medicines; Taiho Pharmaceutical; Xilio Therapeutics
Research Funding - A2 Biotherapeutics (Inst); Affini-T Therapeutics (Inst); Agenus (Inst); Amgen (Inst); Bold Therapeutics (Inst); Camurus (Inst); Cardiff Oncology (Inst); CG Pharmaceuticals (Inst); Crinetics Pharmaceuticals (Inst); Exelixis (Inst); Gilead Sciences (Inst); Gritstone Bio (Inst); Janssen Oncology (Inst); Lyell Immunopharma (Inst); Merck (Inst); Mirati Therapeutics (Inst); Neogene Therapeutics (Inst); NGM Biopharmaceuticals (Inst); Regeneron (Inst); Revolution Medicines (Inst); Seagen (Inst); Tizona Therapeutics, Inc. (Inst); Tizona Therapeutics, Inc. (Inst); Xilio Therapeutics (Inst)
 
Jennifer Specht
Honoraria - BioNTech SE; Daiichi Sankyo; SCRIPPS Research Institute; Sensei Biotherapeutics
Consulting or Advisory Role - BioNTech SE; Boehringer Ingelheim; Daiichi Sankyo; GE Healthcare; Lyell Immunopharma Inc
Research Funding - A2 Biotherapeutics (Inst); AstraZeneca (Inst); AstraZeneca (Inst); Biocity (Inst); Carisma Therapeutics (Inst); Celcuity (Inst); Genentech (Inst); Lyell Immunopharma (Inst); Merck (Inst); OnKure (Inst); Pfizer (Inst); Seagen (Inst); Xencor (Inst)
Patents, Royalties, Other Intellectual Property - UW CoMotion - Patent Royalty for ROR1 CAR (Inst)
Travel, Accommodations, Expenses - A2 Biotherapeutics; Dava Oncology; GE Healthcare; GlaxoSmithKline; iwCAR-T; Nektar